Reassessment of reimbursement status of ATC-groups C01, C04 and C05
At its meetings on 19 September and 7 November 2006, the Reimbursement Committee discussed the reimbursement status of medicinal products in ATC-groups:
- Medicinal products for cardiac therapy (C01)
- Peripheral vasodilators (C04)
- Vasoprotectives (C05)
Based on its discussions, the Reimbursement Committee is going to make a recommendation for the Danish Medicines Agency.
In the fact box to the right, you can find a link to the documents from Reimbursement Committee meetings (in Danish only).
For further information, please contact Nikolai Laursen on tel.: +45 4488 9102 or the Reimbursement Department, email@example.com .
The Danish Medicines Agency, 29 November 2006